Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis.

Published on Dec 1, 2020in The Lancet Gastroenterology & Hepatology14.789
· DOI :10.1016/S2468-1253(20)30300-9
Keeley M. Fairbrass1
Estimated H-index: 1
(University of Leeds),
Keeley M. Fairbrass1
Estimated H-index: 1
(University of Leeds)
+ 1 AuthorsAlexander C. Ford86
Estimated H-index: 86
(St James's University Hospital)
Sources
Abstract
Summary Background Patients with inflammatory bowel disease (IBD) often report symptoms compatible with irritable bowel syndrome (IBS), which might have an effect on psychological health. However, previous estimates of the magnitude of this issue have not accounted for ongoing inflammation as the potential cause. We updated a previous systematic review and meta-analysis to determine prevalence of IBS-type symptoms in patients with IBD in remission to better quantify the magnitude of this issue. Methods In this systematic review and meta-analysis, Embase, Embase Classic, and MEDLINE were searched (from Jan 1, 2012, to May 11, 2020) to identify prospective case-control or cross-sectional studies reporting prevalence of symptoms meeting diagnostic criteria for IBS in adults with IBD in remission. Studies were required to have recruited an unselected adult population (more than 90% of participants aged ≥16 years) with histologically or radiologically confirmed IBD and include at least 50 participants. Pooled prevalence and odds ratios (ORs) with 95% CIs were calculated according to the definition of remission, criteria used to define IBS-type symptoms, and type of IBD. The association between IBS-type symptom reporting and psychological comorbidity was examined using weighted mean difference (WMD) or standardised mean difference (SMD) in anxiety and depression scores between those reporting IBS-type symptoms and those not, for cases in which these data were available. Findings Of 3370 studies identified, 27 were eligible, of which 18 were newly identified. Among 3169 patients with IBD in remission, pooled prevalence of IBS-type symptoms was 32·5% (95% CI 27·4–37·9; I2=90·1%). Prevalence was lower when remission was defined by endoscopic assessment (23·5%, 95% CI 17·9–29·6; I2=59·9%) or histological assessment (25.8%, 95% CI 20.2–31.7; I2=not applicable) than when defined by validated clinical disease activity index (33·6%, 26·3–41·2; I2=91·8%) and higher in Crohn's disease than in ulcerative colitis (36·6%, 29·5–44·0; I2=82·9% vs 28·7%, 22·9–34·8; I2=87·2%). Anxiety (WMD 2·5; 95% CI 0·8–4·3) and depression (SMD 0·64; 0·44–0·84) scores were significantly higher among those who reported IBS-type symptoms than in those who did not. Interpretation Prevalence of symptoms compatible with IBS in patients with IBD varied according to how remission was defined. However, even when stringent criteria such as endoscopic or histological remission were used, about a quarter of patients reported these symptoms. Such symptoms were more common in patients with Crohn's disease and were associated with psychological comorbidity. Addressing psychological wellbeing might improve outcomes in this specific group of patients. Funding None.
📖 Papers frequently viewed together
9 Citations
48 Citations
201519.82Gut
References65
Newest
#1Priya Oka (University of Leeds)H-Index: 1
#2Heather Parr (University of Leeds)H-Index: 1
Last. Alexander C. Ford (University of Leeds)H-Index: 86
view all 6 authors...
Summary Background Irritable bowel syndrome (IBS) is one of the most common functional bowel disorders, but community prevalence appears to vary widely between different countries. This variation might be due to the fact that previous cross-sectional surveys have neither applied uniform diagnostic criteria nor used identical methodology, rather than being due to true global variability. We aimed to determine the global prevalence of IBS. Methods We did a systematic review and meta-analysis of da...
24 CitationsSource
#1Muhammet Ozer (Dokuz Eylül University)H-Index: 2
#2Göksel Bengi (Dokuz Eylül University)H-Index: 7
Last. Hale Akpinar (Dokuz Eylül University)H-Index: 16
view all 5 authors...
Irritable bowel syndrome (IBS)-like symptoms tend to be common in inflammatory bowel disease (IBD) patients even during the long-standing remission phase, and quality of life (QOL) seem to reduce in IBD patients with such symptoms. Thus, the aim of this study was to define the prevalence of IBS-like symptoms in inactive IBD patients using Rome IV criteria and evaluate the effect of IBS-like symptoms on QOL.Total 137 patients with IBD (56 with ulcerative colitis (UC) and 81 with Crohn disease (CD...
2 CitationsSource
#1Selina R Cox ('KCL': King's College London)H-Index: 5
#2James O. Lindsay (QMUL: Queen Mary University of London)H-Index: 57
Last. Kevin Whelan ('KCL': King's College London)H-Index: 63
view all 15 authors...
Abstract Background & Aims There is limited evidence that a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) reduces gut symptoms in quiescent inflammatory bowel disease (IBD). We performed a randomized, controlled trial to investigate the effects of a low-FODMAP diet on persistent gut symptoms, the intestinal microbiome, and circulating markers of inflammation in patients with quiescent IBD. Methods We performed a single-blind trial of 52 patients ...
51 CitationsSource
#1Sudabeh Alatab (Tehran University of Medical Sciences)H-Index: 15
#2Sadaf Ghajarieh Sepanlou (Shiraz University of Medical Sciences)
Last. Mohsen NaghaviH-Index: 142
view all 85 authors...
Summary Background The burden of inflammatory bowel disease (IBD) is rising globally, with substantial variation in levels and trends of disease in different countries and regions. Understanding these geographical differences is crucial for formulating effective strategies for preventing and treating IBD. We report the prevalence, mortality, and overall burden of IBD in 195 countries and territories between 1990 and 2017, based on data from the Global Burden of Diseases, Injuries, and Risk Facto...
191 CitationsSource
#1Shujing Jane Lim (St James's University Hospital)H-Index: 1
#2David J. Gracie (University of Leeds)H-Index: 16
Last. Christopher J Black (University of Leeds)H-Index: 13
view all 8 authors...
BACKGROUND: 23-seleno-25-homo-tauro-cholic acid (SeHCAT) scanning to rule out bile acid diarrhea (BAD) in patients with chronic diarrhea has a high yield. Our previous study showed that patients with terminal ileal (TI) Crohn's disease, TI resection, or cholecystectomy were highly likely to have an abnormal scan. As a result, we encouraged clinicians to use a therapeutic trial of a bile acid sequestrant in these patients, instead of scanning. This may have reduced diagnostic yield of the test, s...
5 CitationsSource
#1David J. Gracie (St James's University Hospital)H-Index: 16
#2P John Hamlin (St James's University Hospital)H-Index: 12
Last. Alexander C. Ford (University of Leeds)H-Index: 86
view all 3 authors...
Summary Brain–gut interactions affect psychological wellbeing and symptom reporting in functional gastrointestinal disorders; the presence of anxiety or depression is associated with the development of new-onset gastrointestinal symptoms, and the presence of gastrointestinal symptoms is associated with the development of psychological disorders de novo. In inflammatory bowel diseases (IBD), the reporting of irritable bowel syndrome (IBS)-type symptoms by patients with quiescent disease is common...
33 CitationsSource
#1Gianluca Ianiro (UCSC: Catholic University of the Sacred Heart)H-Index: 36
#2Leonardo Henry Eusebi (UNIBO: University of Bologna)H-Index: 25
Last. Alexander C. Ford (University of Leeds)H-Index: 86
view all 6 authors...
BACKGROUND: Increasing evidence supports the role of the gut microbiota in the aetiology of irritable bowel syndrome (IBS). Faecal microbiota transplantation (FMT) is a highly effective treatment against recurrent Clostridioides difficile infection in randomised controlled trials (RCTs), and may be beneficial in ulcerative colitis. However, its efficacy in IBS is uncertain. AIM: To perform a systematic review and meta-analysis to examine this issue. METHODS: We searched MEDLINE, EMBASE, EMBASE C...
50 CitationsSource
#1Mohammad Reza Zamani (Babol University of Medical Sciences)H-Index: 15
#2Shaghayegh Alizadeh-Tabari (Babol University of Medical Sciences)H-Index: 2
Last. Vahid Zamani (Babol University of Medical Sciences)H-Index: 4
view all 3 authors...
BACKGROUND: Irritable bowel syndrome (IBS) is a common and potential disabling functional gastrointestinal disorder. Studies have revealed a possible association between IBS and psychological problems, such as anxiety and depression. Existing systematic reviews have addressed only the levels of anxiety or depression in patients with IBS. AIM: To investigate systematically the prevalence of anxiety or depression in IBS patients METHODS: A literature search was conducted using the related keywords...
48 CitationsSource
#1Gaurav B. NigamH-Index: 3
#2Jimmy K. LimdiH-Index: 17
Last. Dipesh H. VasantH-Index: 10
view all 4 authors...
2 CitationsSource
#1Marie Skov Kristensen (University of Southern Denmark)H-Index: 4
#2Thora Majlund Kjærulff (University of Southern Denmark)H-Index: 6
Last. Lau Caspar Thygesen (University of Southern Denmark)H-Index: 30
view all 6 authors...
BACKGROUND: Psychiatric comorbidity might modify the disease course adversely in patients with inflammatory bowel disease (IBD). Treatment options include antidepressants, which, apart from improving mood, have anti-inflammatory properties that might modify the disease course. This nationwide study aimed to examine the influence of antidepressants on the disease course among patients with ulcerative colitis (UC) and Crohn's disease (CD). METHODS: Patients registered with an incident diagnosis of...
10 CitationsSource
Cited By6
Newest
#1Keeley M. Fairbrass (University of Leeds)H-Index: 2
#2David J. Gracie (University of Leeds)H-Index: 16
Last. Alexander C. Ford (University of Leeds)H-Index: 86
view all 0 authors...
BACKGROUND Psychological co-morbidity is more common in patients with inflammatory bowel disease (IBD), compared with the general population, but little is known about the cumulative effect of increasing psychological burden on disease behaviour. AIMS To examine the effect of psychological co-morbidity on inflammatory bowel disease in a longitudinal follow-up study. METHODS We collected complete demographic, symptom and psychological co-morbidity data (anxiety, depression and somatisation scores...
Source
#1Keeley M. Fairbrass (St James's University Hospital)H-Index: 2
#1Keeley M. Fairbrass (University of Leeds)H-Index: 1
Last. David J. Gracie (St James's University Hospital)H-Index: 16
view all 2 authors...
Source
Source
#1Silvio Danese (Humanitas University)H-Index: 100
#2Tommaso Lorenzo Parigi (Humanitas University)H-Index: 6
Last. Subrata Ghosh (NUI: National University of Ireland)
view all 4 authors...
Source
Source
#1Vivek C. Goodoory (University of Leeds)
#2Lesley A. Houghton (University of Leeds)H-Index: 53
Last. Alexander C. Ford (University of Leeds)H-Index: 86
view all 8 authors...
ABSTRACT Objectives Irritable bowel syndrome (IBS) is a chronic functional bowel disorder diagnosed using the Rome criteria, which have evolved since their original description 30 years ago. Little is known about the effects on the natural history of IBS of moving to the latest iteration, Rome IV, from the previous Rome III criteria. We conducted a 12-month longitudinal follow-up study examining this. Methods We collected complete demographic, symptom, mood, and psychological health data at base...
Source
#1Brigida Barberio (UNIPD: University of Padua)H-Index: 7
#2Yan Yiannakou (County Durham and Darlington NHS Foundation Trust)H-Index: 13
Last. Alexander C. Ford (University of Leeds)H-Index: 86
view all 6 authors...
ABSTRACT Objectives Disorders of gut-brain interaction, such as irritable bowel syndrome (IBS) and functional dyspepsia (FD) frequently overlap, but the impact of this on the natural history is unknown. We examined this issue in a longitudinal follow-up study conducted in a large cohort of individuals. Methods We collected complete demographic, symptom, mood, and psychological health data from 1374 adults who self-identified as having IBS. We applied the Rome IV criteria to examine what proporti...
Source
#1Yip Han Chin (NUS: National University of Singapore)H-Index: 3
Last. Mark Dhinesh MuthiahH-Index: 1
view all 8 authors...
NODAT (new-onset diabetes after transplantation) is an important complication after liver transplant, however, there is variation in the reported incidence of NODAT. Therefore, a meta-analysis was performed to estimate the incidence of NODAT in liver transplant. Electronic databases were searched for articles regarding NODAT incidence after liver transplantation. Incidence of NODAT were analyzed at six different timepoints. Summary statistics were calculated using a generalized linear mixed mode...
Source
#1Imran Aziz (University of Sheffield)H-Index: 21
#2Magnus Simrén (UNC: University of North Carolina at Chapel Hill)H-Index: 78
Irritable bowel syndrome (IBS) is a common functional bowel disorder characterised by symptoms of recurrent abdominal pain associated with a change in bowel habit. This condition is one of the most frequent reasons to seek a gastroenterology consultation in primary and secondary care. The diagnosis of IBS is made by identifying characteristic symptoms, as defined by the Rome criteria, and excluding organic gastrointestinal diseases that might otherwise explain these symptoms. Organic conditions ...
2 CitationsSource
#1Patrycja Szałwińska (Medical University of Łódź)H-Index: 1
#2Jakub Włodarczyk (Medical University of Łódź)H-Index: 3
Last. Marcin Włodarczyk (Medical University of Łódź)H-Index: 11
view all 5 authors...
Irritable bowel syndrome (IBS) is a functional heterogenous disease with a multifactorial pathogenesis. It is characterized by abdominal pain, discomfort, and alteration in gut motility. The occurrence of similar symptoms was observed in patients in clinical remission of inflammatory bowel diseases (IBD) that is Crohn’s disease (CD) and ulcerative colitis (UC), which pathogenesis is also not fully understood. Hence, arose the question if these symptoms are “true IBS” imposed on IBD, or is it a s...
2 CitationsSource